Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26790922

Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2016 Feb
First author
Hayes AJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Feb;17(2):127-128. doi: 10.1016/S1470-2045(15)00556-2.
    note
    Source null
    related pmid
    26790923
    relationship
    Comment in

Authors and identifiers

  1. name
    Hayes AJ
    type
    Author
  2. name
    Maynard L
    type
    Author
  3. name
    Coombes G
    type
    Author
  4. name
    Newton-Bishop J
    type
    Author
  5. name
    Timmons M
    type
    Author
  6. name
    Cook M
    type
    Author
  7. name
    Theaker J
    type
    Author
  8. name
    Bliss JM
    type
    Author
  9. name
    Thomas JM
    type
    Author
  10. name
    UK Melanoma Study Group
    type
    CollectiveName
  11. name
    British Association of Plastic
    type
    CollectiveName
  12. name
    Reconstructive and Aesthetic Surgeons, and the Scottish Cancer Therapy Network
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Hayes AJ
    type
    Author
  2. name
    Maynard L
    type
    Author
  3. name
    Coombes G
    type
    Author
  4. name
    Newton-Bishop J
    type
    Author
  5. name
    Timmons M
    type
    Author
  6. name
    Cook M
    type
    Author
  7. name
    Theaker J
    type
    Author
  8. name
    Bliss JM
    type
    Author
  9. name
    Thomas JM
    type
    Author
  10. name
    UK Melanoma Study Group
    type
    CollectiveName
  11. name
    British Association of Plastic
    type
    CollectiveName
  12. name
    Reconstructive and Aesthetic Surgeons, and the Scottish Cancer Therapy Network
    type
    CollectiveName
bibliography ids
  1. nci-bib-b4b515bada9f4ae034ea8a77
book metadata
content sha256
aad91849c0cdee4b6bbba51e9aa5c888236f4c0d7cd869d292474847cb77aad3
document type
citation
dois
  1. 10.1016/S1470-2045(15)00482-9
electronic publication date
display
2016 Jan 12
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:26790922
immutable id
pubmed:26790922@aad91849c0cdee4b6bbba51e9aa5c888236f4c0d7cd869d292474847cb77aad3
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
184-192
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Feb;17(2):127-128. doi: 10.1016/S1470-2045(15)00556-2.
    note
    Source null
    related pmid
    26790923
    relationship
    Comment in
outcomes validated
false
pmid
26790922
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
06a3fa428e495c375309af25795151c9db21c3548a0b836ae6ead077946db798
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Feb
precision
month
year
2016
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26790922/
title
Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.

Preserved source evidence · Not medical advice